Ambrx Biopharma, Inc. Quarterly General and Administrative Expense in USD from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Ambrx Biopharma, Inc. quarterly General and Administrative Expense history and growth rate from Q3 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. General and Administrative Expense for the quarter ending September 30, 2023 was $9.41M, a 84.7% increase year-over-year.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $9.41M +$4.32M +84.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q3 2022 $5.1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.